1.A case in which sodium valproate through a percutaneous endoscopic gastrostomy tube was effective for delirium in a terminal cancer patient
Kozue Suzuki ; Toshiya Kuroda ; Dai Shimazu ; Yuki Fujii ; Yuri Miyazaki ; Takashi Maeda ; Keiko Tanaka
Palliative Care Research 2013;8(1):529-533
Purpose: We report a case in which oral sodium valproate through a percutaneous endoscopic gastrostomy (PEG) tube for palliative decompression drainage in inoperable ileus achieved an effective drug concentration and ameliorated delirium and extrapyramidal side effects. Case Report: The patient was a male in his seventies who suffered from bladder cancer. He underwent PEG because of paralytic ileus with cancerous peritonitis. He had been receiving continuous intravenous infusion of haloperidol for the management of delirium, but needed to discontinue treatment with this agent due to tremor, an extrapyramidal side effect of haloperidol. Oral sodium valproate was therefore administered through the PEG tube for palliative decompression drainage. Plasma valproate concentrations showed effective levels, and his irritability was relieved. A good combination of sodium valproate and quetiapine fumarate allowed successful reduction of and eventual withdrawal from haloperidol, and tremor then improved. Conclusion: We often encounter difficulty with symptom control for patients who cannot use oral medications. When medication by other routes is difficult, this case suggests that sodium valproate through a PEG tube for palliative decompression drainage may be useful as a last resort for improving delirium.
2.A survey of the death attitude of pharmacy students finished clinical training using the Death Attitude Inventory
Munetoshi Sugiura ; Seiichiro Kuroda ; Mikiko Kaitsu ; Sumako Nakajima ; Satoru Iwase ; Yuki Nakajima ; Katsuyoshi Uchino ; Hiroshi Suzuki
Palliative Care Research 2013;8(2):319-325
Purpose: Pharmacists should play a positive role in palliative care. The pharmacy curriculum should also contain content promoting an appropriate attitude toward death. Hence, this study aims to gather fundamental information that can be used to understand the various death attitudes held by pharmacy students. Methods: We targeted 159 sixth-year students of the School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, in 2011. They studied "Up-to-date-Palliative-Care" (an elective subject). To investigate their overall perception of death, we used the Death Attitude Inventory (DAI), developed by Hirai and others (2000), and investigated their views of death on the basis of seven factors. We also classified students on the basis of type of death they had experienced, that is, the death of a household, relative, friend, or pet. We compared the scores obtained for each factor and conducted a logistic regression analysis. Results and Conclusion: We analyzed the data from 120 students (valid response rate: 75.5%). Students who had experienced the death of friend, had significantly higher scores on "Life Purpose" and "Death Concern" (p<0.05). Students who had experienced the death of household etc., statistical positive correlation with "Death Concern" and statistical negative correlation with "Death Anxiety" were recognized.
3.Concomitant Transapical Transcatheter Aortic Valve Replacement and Off-Pump Coronary Artery Revascularization
Yuki Kuroda ; Yoshio Arai ; Keisuke Hakamada ; Masafumi Kudo ; Takashi Tsuji ; Hiroo Teranishi ; Hideki Tsubota ; Michiya Hanyu
Japanese Journal of Cardiovascular Surgery 2017;46(3):119-121
An 84-year-old woman with severe aortic stenosis (AS) and coronary artery disease (CAD) was admitted repeatedly with syncope and heart failure. Due to her comorbidities, concomitant transapical transcatheter aortic valve replacement (TAVR) and off-pump coronary artery bypass grafting (OPCAB) were performed. She did well postoperatively. CAD is often found concurrently in patients presenting with severe symptomatic AS. Concomitant TAVR and OPCAB is considered as a less invasive and more feasible treatment option in high-risk patients.
4.Hemolytic Anemia after Mitral Valve Surgery
Yuki Kuroda ; Kenji Minakata ; Kazuhiro Yamazaki ; Hisashi Sakaguchi ; Shingo Hirao ; Shinya Takimoto ; Kazuhisa Sakamoto ; Tomohiro Nakata ; Tadashi Ikeda ; Ryuzo Sakata
Japanese Journal of Cardiovascular Surgery 2016;45(2):67-72
Objective : The aim of this study is to describe a series of patients undergoing reoperation due to hemolytic anemia after mitral valve surgery and assess the mechanisms and surgical outcomes. Methods : Between 2009 and 2014, we performed redo mitral valve surgery in 11 patients who had refractory hemolytic anemia after mitral valve surgery at Kyoto University Hospital. The mean age of the patients was 72.2±6.8 years old, and there were 5 men. Results : Preoperative echocardiography demonstrated that only 3 patients had ≥ grade 3 mitral regurgitation (MR), the rest of the patients had only mild to moderate MR. The mechanisms of severe hemolysis included paravalvular leakage (PVL) after mitral valve replacement (MVR) in 8 patients, structural valve deterioration (SVD) after MVR using a bioprosthesis in one, and residual/recurrent mitral regurgitation after mitral valve plasty (MVP) in two. All the patients except one (re-MVP) underwent MVR. The mean interval between previous operation and current operation was 14.1±9.4 years in post-MVR cases, and 2.0±1.9 years in post-MVP cases. There were three late deaths, one of which was due to cardiac death (exacerbation of heart failure due to pneumonia). There was one patient who required re-MVR for recurrent hemolysis due to PVL after MVR. Conclusion : Although hemolytic anemia after mitral valve surgery is rare, it often requires reoperation regardless of the degree of MR at late follow-up period. Thus, patients after mitral valve surgery should be carefully followed-up.
5.Enhanced case finding and self-isolation measures in the early phase of SARS-CoV-2 Omicron transmission, Osaka, Japan, December 2021–January 2022
Miho Kobayashi ; Kensaku Kakimoto ; Yuichiro Yahata ; Yusuke Kobayashi ; Hitomi Nagai ; Chisato Tanikake ; Kazumi Fukumura ; Keiko Date ; Hiromi Murata ; Sae Kitagawa ; Yuki Yoshida ; Yui Kamoda ; Miho Akazaki ; Masaaki Tanabe ; Chika Shirai ; Tomoe Shimada ; Taro Kamigaki ; Tsuyoshi Sekizuka ; Makoto Kuroda ; Tomimasa Sunagawa
Western Pacific Surveillance and Response 2025;16(2):29-38
Objective: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.529 (Omicron) was first detected in Japan in November 2021. In Osaka, public health centres subsequently increased active case finding and encouraged self-isolation. This study investigated the effectiveness of these countermeasures.
Methods: Cases targeted for analysis were persons who had neither recently travelled abroad nor had contact with foreign tourists but tested positive for SARS-CoV-2 between 24 November 2021 and 4 January 2022 and were suspected or confirmed to have the Omicron variant. We performed a descriptive analysis and calculated the reproduction number (R) for each generation using the branching process method. Genomic sequencing data were analysed to plot a haplotype network.
Results: A total of 251 cases were analysed. The median age was 30 years, and 46% (115/251) were in their 20s or younger. The first Omicron case in Osaka was detected on 21 December 2021. Local public health centres conducted health monitoring and contact tracing. We analysed R, using information from six clusters, including 42 pairs with a clear relationship between the case and the infected contact (infector–infectee pairs); the clusters had 19, 21 and 2 cases in each subsequent generation. The basic R (t = 0) was estimated to be 3.2, and subsequent generations (t = 1, 2) of R decreased to 1.1 and 0.1, respectively. The haplotype network showed that these cases constituted a monophyletic group with others detected around Osaka, indicating that these case-related clusters had been contained and were not involved in the nationwide Omicron waves.
Discussion: Active case finding and self-isolation were found to be effective in limiting the spread of an emerging novel variant.